These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28920704)

  • 1. Endothelial-to-Mesenchymal Transition: A Potential Mechanism for Atherosclerosis Plaque Progression and Destabilization.
    Li A; Peng W; Xia X; Li R; Wang Y; Wei D
    DNA Cell Biol; 2017 Nov; 36(11):883-891. PubMed ID: 28920704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial-to-mesenchymal transition shapes the atherosclerotic plaque and modulates macrophage function.
    Helmke A; Casper J; Nordlohne J; David S; Haller H; Zeisberg EM; von Vietinghoff S
    FASEB J; 2019 Feb; 33(2):2278-2289. PubMed ID: 30260706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype.
    Lecce L; Xu Y; V'Gangula B; Chandel N; Pothula V; Caudrillier A; Santini MP; d'Escamard V; Ceholski DK; Gorski PA; Ma L; Koplev S; Bjørklund MM; Björkegren JL; Boehm M; Bentzon JF; Fuster V; Kim HW; Weintraub NL; Baker AH; Bernstein E; Kovacic JC
    J Clin Invest; 2021 Aug; 131(15):. PubMed ID: 34338228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis.
    Wesseling M; Sakkers TR; de Jager SCA; Pasterkamp G; Goumans MJ
    Vascul Pharmacol; 2018 Jul; 106():1-8. PubMed ID: 29471141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CLOCK under high glucose upregulates ROCK1-mediated endothelial to mesenchymal transition and aggravates plaque vulnerability.
    Tang H; Zhu M; Zhao G; Fu W; Shi Z; Ding Y; Tang X; Guo D
    Atherosclerosis; 2018 Aug; 275():58-67. PubMed ID: 29860109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of miR-122 reduced atherosclerotic lesion formation by regulating NPAS3-mediated endothelial to mesenchymal transition.
    Wu X; Du X; Yang Y; Liu X; Liu X; Zhang N; Li Y; Jiang X; Jiang Y; Yang Z
    Life Sci; 2021 Jan; 265():118816. PubMed ID: 33278397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability.
    Evrard SM; Lecce L; Michelis KC; Nomura-Kitabayashi A; Pandey G; Purushothaman KR; d'Escamard V; Li JR; Hadri L; Fujitani K; Moreno PR; Benard L; Rimmele P; Cohain A; Mecham B; Randolph GJ; Nabel EG; Hajjar R; Fuster V; Boehm M; Kovacic JC
    Nat Commun; 2016 Jun; 7():11853. PubMed ID: 27340017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases.
    Jackson AO; Zhang J; Jiang Z; Yin K
    Trends Cardiovasc Med; 2017 Aug; 27(6):383-393. PubMed ID: 28438397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-mesenchymal transition in atherosclerosis.
    Souilhol C; Harmsen MC; Evans PC; Krenning G
    Cardiovasc Res; 2018 Mar; 114(4):565-577. PubMed ID: 29309526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress.
    Moonen JR; Lee ES; Schmidt M; Maleszewska M; Koerts JA; Brouwer LA; van Kooten TG; van Luyn MJ; Zeebregts CJ; Krenning G; Harmsen MC
    Cardiovasc Res; 2015 Dec; 108(3):377-86. PubMed ID: 26084310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EndMT: Potential Target of H
    Liu HT; Zhou ZX; Ren Z; Yang S; Liu LS; Wang Z; Wei DH; Ma XF; Ma Y; Jiang ZS
    Curr Med Chem; 2021; 28(18):3666-3680. PubMed ID: 33200693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endothelial-mesenchymal transition in development and pathological process.
    Lin F; Wang N; Zhang TC
    IUBMB Life; 2012 Sep; 64(9):717-23. PubMed ID: 22730243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial to mesenchymal transition in atherosclerotic vascular remodeling.
    Hao YM; Yuan HQ; Ren Z; Qu SL; Liu LS; Dang-HengWei ; Yin K; Fu M; Jiang ZS
    Clin Chim Acta; 2019 Mar; 490():34-38. PubMed ID: 30571947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endothelial-to-mesenchymal transition in cancer progression.
    Potenta S; Zeisberg E; Kalluri R
    Br J Cancer; 2008 Nov; 99(9):1375-9. PubMed ID: 18797460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic Plaque Destabilization in Mice: A Comparative Study.
    Hartwig H; Silvestre-Roig C; Hendrikse J; Beckers L; Paulin N; Van der Heiden K; Braster Q; Drechsler M; Daemen MJ; Lutgens E; Soehnlein O
    PLoS One; 2015; 10(10):e0141019. PubMed ID: 26492161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.
    Andreou I; Antoniadis AP; Shishido K; Papafaklis MI; Koskinas KC; Chatzizisis YS; Coskun AU; Edelman ER; Feldman CL; Stone PH
    J Cardiovasc Pharmacol Ther; 2015 May; 20(3):261-75. PubMed ID: 25336461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial to mesenchymal transition contributes to nicotine-induced atherosclerosis.
    Qin W; Zhang L; Li Z; Xiao D; Zhang Y; Zhang H; Mokembo JN; Monayo SM; Jha NK; Kopylov P; Shchekochikhin D; Zhang Y
    Theranostics; 2020; 10(12):5276-5289. PubMed ID: 32373212
    [No Abstract]   [Full Text] [Related]  

  • 19. BMAL1 suppresses ROS-induced endothelial-to-mesenchymal transition and atherosclerosis plaque progression via BMP signaling.
    Zhu M; Tang H; Tang X; Ma X; Guo D; Chen F
    Am J Transl Res; 2018; 10(10):3150-3161. PubMed ID: 30416657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial-mesenchymal transition via CCL-4.
    Yang Y; Luo NS; Ying R; Xie Y; Chen JY; Wang XQ; Gu ZJ; Mai JT; Liu WH; Wu MX; Chen ZT; Fang YB; Zhang HF; Zuo ZY; Wang JF; Chen YX
    Int J Mol Med; 2017 Aug; 40(2):558-568. PubMed ID: 28656247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.